In conclusion, while decisions regarding trachoma MDA have usually relied on TF prevalence, which until recently was the only feasible option in the field for assessing trachoma, it is now possible, as illustrated here, to integrate testing for current and previous C. trachomatis infection. The gene discussed is TF; the disease is inclusion conjunctivitis.